Kura Oncology, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2016 | $-25.3M | $-25.3M | — | $2.1M |
| FY2017 | $-28.4M | $-28.4M | — | $4.5M |
| FY2018 | $-48.7M | $-48.7M | — | $8.7M |
| FY2019 | $-54.8M | $-54.8M | — | $9.4M |
| FY2020 | $-69.8M | $-72.0M | $2.2M | $12.8M |
| FY2021 | $-104.6M | $-105.7M | $1.1M | $23.6M |
| FY2022 | $-110.1M | $-110.7M | $626.0K | $26.3M |
| FY2023 | $-124.8M | $-125.0M | $168.0K | $28.1M |
| FY2024 | $134.3M | $133.8M | $472.0K | $33.9M |
| FY2025 | $-64.1M | $-70.7M | $6.6M | $37.1M |